Jubilant Pharmova Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
1,000.00 +4.65 (0.47%)Updated : 14 May 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 6,068.206,348.706,108.725,305.71
Other Net 0.20-0.50-8.321.44
Diluted Weighted Average Shares 15.8915.8915.9115.92
Depreciation/ Amortization 368.60381.90382.60381.70
Operating Income 1,166.30354.20173.01824.45
Net Income 839.4077.10-60.98413.94
Income Availableto Com Excl Extra Ord 839.4077.10-60.98413.94
Other Operating Expenses Total 52.0057.8056.0329.93
Net Income Before Taxes 980.60170.5027.78630.45
Minority Interest 3.104.403.900.92
Net Income After Taxes 836.3072.70-64.88413.02
Income Availableto Com Incl Extra Ord 839.4077.10-60.98413.94
Costof Revenue Total 2,765.902,571.002,389.501,921.29
Gross Profit 4,468.604,131.903,892.234,208.88
Interest Inc( Exp) Net- Non- Op Total -185.90-183.20-134.25-192.08
Unusual Expense( Income) -359.50168.90228.240.00
Diluted Net Income 839.4077.10-60.98413.94
DPS- Common Stock Primary Issue 5.005.005.005.00
Provisionfor Income Taxes 144.3097.8092.66217.43
period Type ----
Net Income Before Extra Items 839.4077.10-60.98413.94
Total Revenue 7,234.506,702.906,281.736,130.16
period Length 12.0012.0012.0012.00
Revenue 7,234.506,702.906,281.736,130.16
Selling/ General/ Admin Expenses Total 3,241.203,169.103,052.342,972.79
Diluted Normalized EPS 33.549.395.6026.14
Diluted EPS Excluding Extra Ord Items 52.844.85-3.8326.01
Gain( Loss)on Saleof Assets ---2.66-3.37
Total Extraordinary Items ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
4,513.40+204.90(4.76%)
2,600.00+70.55(2.79%)
1,019.55-72.25 (-6.62%)
954.60-17.95 (-1.85%)